A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Digital technologies loom large on the list—from the growing impact of artificial intelligence to the need for tech-enabled ...

Are you looking for prescription drugs like Ozempic, Wegovy, and Mounjaro online? You’re not alone. However, shopping for ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Achieving and maintaining a healthy weight is beneficial for a number of reasons. A healthy weight lowers a person's chance ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide in ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

By Dennis Thompson HealthDay Reporter THURSDAY, Jan. 2, 2024 (HealthDay News) -- Weight loss tops many folks’ list ... These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 ...

While the FDA had considered Lilly's (LLY) tirzepatide and Novo Nordisk's (NVO) semaglutide in short supply for months, Lilly's (LLY) products were taken off the shortage list in October.